A patent review of butyrylcholinesterase inhibitors and reactivators 2010–2017
Sign Up to like & getrecommendations! Published in 2018 at "Expert Opinion on Therapeutic Patents"
DOI: 10.1080/13543776.2018.1476494
Abstract: ABSTRACT Introduction: Butyrylcholinesterase (BuChE) has obtained a renewed interest as therapeutic target in Alzheimer’s disease (AD), when changes in BuChE activity and expression along disease progression were highlighted as well as correlation between BuChE levels… read more here.
Keywords: patent review; butyrylcholinesterase; buche inhibitors; buche ... See more keywords